HER2 Heterogeneity Impacts Response Rates in HER2-Positive Breast Cancer

A trial presented at ASCO 2019 found HER2 heterogenity can impact response rates to some treatments in HER2-positive breast cancer patients.

Source: CancerNetwork - July 19, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news